Clinical Trials Logo

Filter by:
NCT ID: NCT00148980 Withdrawn - Clinical trials for Myelodysplastic Syndromes

Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation

Start date: April 2003
Phase: Phase 2
Study type: Interventional

Normal bone marrow function depends on the coexistence of normal hematopoietic stem cells and a microenvironment mostly located in the medullary part of the bones. Stem cells cannot function properly in the absence of an adequate microenvironment. Whereas in malignant and non-malignant hematologic diseases caused by a deficiency or abnormal stem cells, stem cell transplantation is the treatment of choice that results in a cure, in diseases such as MDS, myelofibrosis, and other conditions associated with an abnormal microenvironment, pancytopenia may occur despite the presence of apparently normal hematopoietic cells with no recognizable cytogenetic abnormality. We, the investigators at Hadassah Medical Organization, proved in experimental studies that the entire osteohematopoietic complex consisting of trabecular bone, hematopoietic microenvironment (of stromal origin) and hematopoietic tissue has been successfully transferred directly into ablated bone marrow cavity in a one-step transplantation procedure. The goal of this study is to enhance hematopoiesis in patients with myelofibrosis syndrome by intraosseous inoculation of demineralized bone matrix (DBM) together with allogeneic bone marrow cells (BMC).

NCT ID: NCT00148447 Completed - Schizophrenia Clinical Trials

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The aim of this study is to evaluate the therapeutic effect of escitalopram in the treatment of negative symptoms in schizophrenia patients in a double-blind placebo-controlled study.

NCT ID: NCT00147602 Completed - Clinical trials for Cardiovascular Disease

Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke

SPARCL
Start date: November 1998
Phase: Phase 4
Study type: Interventional

To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.

NCT ID: NCT00147355 Terminated - HIV Infections Clinical Trials

Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy

Start date: November 2005
Phase: Phase 3
Study type: Interventional

This substudy is an open-label, randomised study comparing the uptake of recombinant interleukin-2 (rIL-2) in HIV-1 infected individuals receiving different combinations of antiemetics and analgesic agents during rIL-2 dosing in ESPRIT. The design is a factorial one with 4 arms. All patients will receive regular ibuprofen and paracetamol from days 1-6 of the rIL-2 dosing cycle; in addition, patients will be randomised to receive one of two antiemetic combinations, i.e. ondansetron or metoclopramide with or without low dose codeine phosphate as an additional analgesic agent.

NCT ID: NCT00147199 Completed - Clinical trials for Pulmonary Hypertension

Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)

TRIUMPH
Start date: June 2005
Phase: Phase 3
Study type: Interventional

This is a double-blind placebo-controlled clinical investigation into the efficacy and tolerability of inhaled treprostinil in patients with severe pulmonary arterial hypertension. The primary outcome is the change in 6-minute walk distance from baseline to week 12.

NCT ID: NCT00147004 Completed - Shock, Septic Clinical Trials

Corticosteroid Therapy of Septic Shock - Corticus

Corticus
Start date: March 2002
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine whether steroids decrease 28-day mortality in patients with septic shock.

NCT ID: NCT00146978 Completed - Clinical trials for Graft vs Host Disease

Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)

Start date: December 2000
Phase: Phase 1/Phase 2
Study type: Interventional

Graft versus host disease (GVHD) is a major complication of allogeneic bone marrow transplantation (BMT), resulting in death in the majority of steroid resistant patients. The study was designed to assess the efficacy of regional intra-arterial treatment in patients with resistant hepatic and/or gastro-intestinal GVHD.

NCT ID: NCT00146900 Completed - Clinical trials for Post-traumatic Stress Disorder

Prevention of Post Traumatic Stress Disorder by Early Treatment

Start date: August 2004
Phase: N/A
Study type: Interventional

To prospectively evaluate the effect of early treatment (cognitive therapy (CT), cognitive-behavioral therapy (CBT) and escitalopram (SSRI) in preventing the occurrence of post-traumatic stress disorder in recent survivors of traumatic events.

NCT ID: NCT00146887 Recruiting - Clinical trials for Atherosclerosis, Coronary

Comparison of Coronary CT Angiography to Invasive Coronary Angiography

Start date: January 2005
Phase: N/A
Study type: Interventional

The purpose of the trial is to investigate the accuracy of coronary CT compared to the conventional "gold standard" cardiac catheterization.

NCT ID: NCT00146263 Withdrawn - Dementia Clinical Trials

Computerized Cognitive Training in the Elderly

CogTrain
Start date: September 2005
Phase: N/A
Study type: Interventional

Background: The aging of the population has lead to a significant increase in the number of older people suffering from cognitive impairment and dementia. The present lack of effective drug therapy for these conditions makes it imperative to investigate other potential therapeutic interventions. Cognitive training has been described as possibly useful in improving cognitive function in elderly subjects with mild impairment and early dementia. However, there have been few well-designed studies to date and the results are equivocal. Most studies have relied on the use of paper-based neuropsychological assessment instruments with limited accuracy and reproducibility. The investigators have developed a validated computerized neuropsychological assessment battery with increased test-retest reliability. The purpose of this study is to assess the efficacy of a computerized training program on cognitive function in older persons with normal cognition, mild cognitive impairment, and early dementia. Description: A randomized prospective AB/BA crossover study. Methods: Eligible males and females aged 60 years and older following initial computerized neuropsychological assessment will be randomized to receive either a 12-session computerized cognitive training program, or no treatment. Repeat neuropsychological assessment will be followed by a 4-week no treatment phase, reassessment and crossover phase.